Georgia Bio Names Milton High School Senior as Georgia BioGENEius Winner

Shreya Ramesh Advances in International Competition Against Top Students 

Atlanta, GA (April 6, 2020)  – Georgia Bio and the Georgia BioEd Institute today named  Shreya Ramesh , a senior at Milton High School in Milton, GA, as the winner of the 2020 Georgia BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research and innovation in the biotechnology field.  As Georgia’s BioGENEius finalist, Shreya will attend the 2020 International BioGENEius competition, which will be held virtually during the BIO Digital Convention.

Shreya will compete against high school students from the U.S., Canada and Germany in the International BioGENEius Challenge. The student projects will represent a range of biotechnology topics such as healthcare, agriculture, and the environment.

Shreya Ramesh headshot
Shreya Ramesh, 2020 Georgia BioGENEius Challenge Winer

Shreya’s award-winning research uses machine learning to assess the voice features of Amyotrophic Lateral Sclerosis (ALS) patients. The voices of ALS patients are characteristically slower, higher pitched, and softer than the voices of individuals who do not have ALS. Using ALS voice feature data, Shreya created a voice compensation algorithm to convert the ALS patient’s voice into one more similar to a non-ALS patient. This allowed the ALS patient’s voice to be better recognized by Automatic Speech Recognition (ARS) programs like Google Voice or Amazon’s Alexa. ALS patients often rely on ARS programs due to their limited mobility, but their voice features are not recognized by these programs.

“The BioGENEius Challenge highlights the breakthroughs made when we invest in and encourage young people to pursue their ideas,” said Georgia Bio President and CEO Maria Thacker. “Georgia Bio is thrilled that Shreya will represent our state at the upcoming BIO Convention. We are proud to support this Georgia scholar as she develops tomorrow’s healthcare innovations.”

Georgia Bio also congratulates the Georgia BioGENEius runner-up,  Krish Wadhwani  of Denmark High School in Alpharetta, GA. Krish’s project focused on the production of synthetic antibody mimics (SyAMs) as treatment for Huntington’s disease (HD) and Alzheimer’s Disease (AD). The SyAMs are engineered antibodies that can bind to the misshapen proteins responsible for causing symptoms in HD and AD. This would inhibit the proteins and help control symptoms of the disease. Krish plans to continue this research and next hopes to get funding to pursue clinical production and testing of the antibodies. 

Krish Wadhwani headshot
Krish Wadhwani, 2020 Georgia BioGENEius Challenge Runner-Up

Judging the 2020 Georgia BioGENEius were Jamie L. Graham, Kilpatrick Townsend & Stockton; Ralph L. Cordell, CDC; and Ian Biggs, UGA.

National and International winners will be announced after the competition. See the  International BioGENEius website  for more information on the revised 2020 schedule. Winners will receive cash scholarships.

# # #

Follow the BioGENEius Challenge:  Throughout the challenge, @BiotechInstitut will be tweeting interviews, photos, and engaging with the biotechnology community by using the hashtag #BioGENEius.

About the Biotechnology Institute

The Biotechnology Institute is an independent, national nonprofit organization dedicated to education about the present and future impact of biotechnology.  Its mission is to engage, excite and educate the public, particularly students and teachers, about biotechnology and its immense potential for solving human health, food and environmental problems.  For more information, visit www.biotechinstitute.org.

About the GeorgiaBioEd Institute 
The Georgia BioEd Institute is a division of Georgia Bio, a 501(c)(3) nonprofit organization serving the state’s life science industry. The Institute’s mission is to strengthen Georgia’s life sciences workforce pipeline through classroom-to-career initiatives that align with industry needs. Learn more at  www.georgiabioed.org  |  www.gabio.org.

MEDIA CONTACT

Maria Thacker
404-920-2042
mthacker@gabio.org

September 11, 2025
Members are invited to join G2G’s Monthly GBG Reporting Service Webinar on September 18, 2025 . The first portion ( 12:00–12:30 PM ET ) is free and open to all, offering a high-level overview of current federal funding trends. The second half ( 12:30–1:00 PM ET ) is a premium consultation available only to Georgia Life Sciences members, offering direct access to G2G’s expert team—who have helped secure over $550 million in non-dilutive government funding since 2007. Register here: https://www.g2gconsulting.com/event/non-dilutive-funding-g2gs-monthly-gbg-reporting-service-webinar-14-3/2025-09-18/ Key opportunities this month include DARPA’s Expedited Research Innovation System for CBRN threat defense technologies, BARDA’s I-CREATE diagnostic funding and VANGUARD biomanufacturing tools development (each offering up to $200,000), NIAID tuberculosis and influenza research units (up to $1.5–$2.5 million annually), DoD’s $4 million Advanced Medical Monitor development through MTEC, and multiple SBIR opportunities for sensors and field-deployable diagnostics (up to $209,575 for Phase I awards). The September GBG report highlights 13 immunology and infectious disease opportunities, 10 cognitive and brain health programs, and several biotechnology and biomanufacturing initiatives across federal agencies including the Army, ARPA-H, BARDA, and NSF. Georgia Life Sciences members can access the complete 29-page report with detailed deadlines and eligibility requirements [insert link or portal instructions here]. GLS members can access the full 29-page report with deadlines and submission details by logging into your member portal.
By Maria Thacker Goethe September 5, 2025
Protecting U.S. Leadership in Agricultural Biotechnology
By Maria Thacker Goethe August 29, 2025
Celebrating the Next Generation of Scientific Breakthroughs in Georgia
MORE POSTS